Cartesian Therapeutics Inc. (RNAC)
Market Closed
30 May, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
9. 56
-0.44
-4.4%
After Hours
$
0 0% 9. 56
259.54M Market Cap
- P/E Ratio
0% Div Yield
42,000 Volume
- Eps
$ 10
Previous Close Day Range
9.36 10.02
Year Range
8.46 41.87
Want to track RNAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RNAC Cartesian Therapeutics Inc. 6 May 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 5 Mar 2025 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 11 Nov 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 15 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 8 Aug 2024 | | - Cons. EPS | 0.54 EPS |
| RNAC Cartesian Therapeutics Inc. 14 Jun 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 2 May 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 7 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 6 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 4 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 1 Mar 2024 | | - Cons. EPS | - EPS |
| RNAC Cartesian Therapeutics Inc. 29 Feb 2024 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
